Zimmer Biomet Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated May 8, 2020, details the results of the annual meeting of shareholders held by Zimmer Biomet Holdings, Inc. on that date. The company is incorporated in Delaware and its common stock trades on the New York Stock Exchange under the symbol ZBH.
Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly a report on corporate governance actions taken at the annual shareholder meeting.
Material Changes
There are no material changes to financial operations or business strategy reported in this filing. The primary events are the election of directors, the ratification of the independent auditor, and the advisory vote on executive compensation.
Shareholder Vote Results
- Proposal 1 (Election of Directors): All 11 nominees were elected. Vote counts ranged from approximately 153.8 million "For" votes for Arthur J. Higgins to 169.4 million "For" votes for Gail K. Boudreaux. Broker non-votes totaled 12,858,434 for all director nominees.
- Proposal 2 (Ratification of Auditor): Shareholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2020. The vote was 177,573,304 "For" versus 4,946,254 "Against".
- Proposal 3 (Say on Pay): Shareholders approved, on an advisory basis, the compensation of named executive officers. The vote was 155,897,279 "For" versus 13,500,867 "Against".
Key Facts for Investor Verification
- Verify the tenure of the newly elected directors, which ends at the 2021 annual meeting.
- Note the significant number of broker non-votes (12,858,434) on the director election and executive compensation proposals, indicating shares held by brokers that were not voted on these matters.
- Confirm the "Against" vote percentage for Arthur J. Higgins (approx. 9.3%) and the "Say on Pay" proposal (approx. 8.0%) as these represent the highest dissent levels among the proposals.
- Review the company's proxy statement for detailed compensation data referenced in Proposal 3.